Clinical trial
Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating…
NCT00017381 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00017381 |
|---|---|
| Title | Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma |
| Official title | Dose Finding Study of IDEC-Y2B8 With Autologous Stem Cell Support |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma and 40 more |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | rituximab, cyclophosphamide, filgrastim, yttrium Y 90 ibritumomab tiuxetan, peripheral blood stem cell transplantation |
| Enrollment | 30 |
| Start date | Apr 1, 2001 |
| Primary completion | Dec 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 9, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: